NRG1 and atherosclerosis: In summary, this is the first study to provide evidence that plasma NRG-1 concentrations are significantly reduced in patients with ASCVD and that measuring NRG-1 concentrations could provide a novel indicator for predicting the prognosis of ASCVD.